-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...

-The New York Times NEW DELHI - The philosophical owner of India's most profitable newspaper used to tell his senior editors that his publication was like a temple. The objective of a temple, he said, was to use the entertainment of rituals and the frivolity of festivals to lead people into the sanctum sanctorum, where more serious matter resided. The outer sections of his newspaper - the dramatic news, the sports...

-The Telegraph Guwahati: Union tourism secretary Pervez Dewan has asked the National Council of Educational Research and Training (NCERT) to remove a sentence in a Class X geography textbook that reads tourism has not been encouraged in the Northeast "for strategic reasons". For Kavya Barnadhya Hazarika, a Class XI student of Maharishi Vidya Mandir Senior Secondary School here, it's a lesson learnt that persistence pays. Kavya had written to both President Pranab...

-The Hindu The order may give rise to property and employment benefit claims relating to unmarried people. Parents could find sexual partners of their children making demands for a share of their assets. The discussion on the Madras High Court verdict on the implications of sexual relationships between unmarried couples has been wide-ranging - from mirthful responses to the suggestion that such liaisons could attain marital status under certain circumstances, to sympathetic...

-The Business Standard Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...